Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Veyong Pharmaceutical Co., Ltd., known as Veyong Pharma, is a prominent Chinese pharmaceutical company specializing in the development, production, and sale of veterinary products and animal health solutions. Established in 1950 and currently a subsidiary of Limin Group, the company has grown into one of the world's largest manufacturing bases for Ivermectin and other essential antiparasitic APIs. Veyong's extensive product portfolio includes various active pharmaceutical ingredients and finished dosages such as Tiamulin, Valnemulin, and Abamectin, serving the livestock, poultry, and companion animal markets. The company operates multiple GMP-certified production lines and maintains a strong international presence, exporting to over 80 countries and regions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veyong Pharma.